ABSTRACT
We sought to quantify how often women with late preterm birth (LPTB) receive antenatal
corticosteroid (ACS) therapy prior to 34 weeks and to determine its effects on neonatal
respiratory morbidity. LPTBs (340 /7 to 366 /7 weeks) over a 1-year period at a single tertiary care hospital were studied. A composite
neonatal respiratory outcome was defined as mechanical ventilation, continuous positive
airway pressure with fraction of inspired oxygen (FIO
2 ) >40% for >2 hours or FIO
2 >40% for >4 hours within the first 72 hours of life. Multivariate logistic regression
analysis was used to evaluate the association between ACS therapy and neonatal respiratory
morbidity. Over the study period, 503 LPTBs met the study criteria and 6.8% (n = 34) had ACS therapy <34 weeks. Most had exposure >7 days prior to delivery (64.7%).
Almost one-half of those receiving prior ACS therapy delivered between 34 and 35 weeks.
There was no difference in the rate of prior ACS therapy based on LPTB indication
for delivery. After adjusting for confounding factors, prior ACS therapy was not associated
with lower respiratory morbidity (odds ratio [OR] 2.0, 95% confidence interval [CI]
0.2 to 16.3, p = 0.53). Advancing gestational age was the only variable associated with respiratory
morbidity (OR 0.50, 95% CI 0.26 to .94, p = 0.03). In our population, prior ACS therapy was infrequent and was not associated
with improvements in neonatal respiratory morbidity following LPTB.
KEYWORDS
Late preterm birth - preterm birth - corticosteroids - antenatal corticosteroids -
neonatal respiratory morbidity
REFERENCES
1
Martin J A, Kirmeyer S, Osterman M, Shepherd R A.
Born a bit too early: recent trends in late preterm births.
NCHS Data Brief.
2009;
24
1-8
2
ACOG Committee on Obstetric Practice .
ACOG Committee Opinion No. 475: Antenatal corticosteroid therapy for fetal maturation.
Obstet Gynecol.
2011;
117
(2 Pt 1)
422-424
3
Roberts D, Dalziel S.
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk
of preterm birth.
Cochrane Database Syst Rev.
2006;
3
CD004454
4 Clinical Trials.gov. 2011. Antenatal Late Preterm Steroids (ALPS): A Randomized
Placebo-Controlled Trial. Available at: http://clinicaltrials.gov/ct2/show/NCT01222247?term=late+preterm+birth+antenatal&rank=2 Accessed March 12, 2011
5
Holland M G, Refuerzo J S, Ramin S M, Saade G R, Blackwell S C.
Late preterm birth: how often is it avoidable?.
Am J Obstet Gynecol.
2009;
201
404
e1-e4
6
Carreno C A, Costantine M M, Holland M G, Ramin S M, Saade G R, Blackwell S C.
Approximately one-third of medically indicated late preterm births are complicated
by fetal growth restriction.
Am J Obstet Gynecol.
2011;
204
263
e1-e4
7
Fuchs K SK, Gyamfi P, Gyamfi C.
The effect of exposure to antenatal corticosteroids on the rate of respiratory morbidity
among late preterm infants [abstract].
Am J Obstet Gynecol.
2008;
199
S44
Available at:
http://download.journals.elsevierhealth.com/pdfs/journals/0002-9378/PIIS0002937808012660.pdf
Accessed June 2011;
8
Bastek J A, Sammel M D, Rebele E C, Srinivas S K, Elovitz M A.
The effects of a preterm labor episode prior to 34 weeks are evident in late preterm
outcomes, despite the administration of betamethasone.
Am J Obstet Gynecol.
2010;
203
140
e1-e7
9
Ventolini G, Neiger R, Mathews L, Adragna N, Belcastro M.
Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation
following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation.
Am J Perinatol.
2008;
25
79-83
10
Ring A M, Garland J S, Stafeil B R, Carr M H, Peckman G S, Pircon R A.
The effect of a prolonged time interval between antenatal corticosteroid administration
and delivery on outcomes in preterm neonates: a cohort study.
Am J Obstet Gynecol.
2007;
196
457
e1-e6
11
McEvoy C, Schilling D, Spitale P, Peters D, O'Malley J, Durand M.
Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation,
delivered more than 7 days after antenatal steroid therapy.
Pediatrics.
2008;
121
e1032-e1038
12
Peaceman A M, Bajaj K, Kumar P, Grobman W A.
The interval between a single course of antenatal steroids and delivery and its association
with neonatal outcomes.
Am J Obstet Gynecol.
2005;
193
(3 Pt 2)
1165-1169
13
Stutchfield P, Whitaker R, Russell I. Antenatal Steroids for Term Elective Caesarean
Section (ASTECS) Research Team .
Antenatal betamethasone and incidence of neonatal respiratory distress after elective
caesarean section: pragmatic randomised trial.
BMJ.
2005;
331
662
14
McIntire D D, Leveno K J.
Neonatal mortality and morbidity rates in late preterm births compared with births
at term.
Obstet Gynecol.
2008;
111
35-41
15
Hibbard J U, Wilkins I, Sun L Consortium on Safe Labor et al.
Respiratory morbidity in late preterm births.
JAMA.
2010;
304
419-425
Carlos A. CarrenoM.D.
Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive
Sciences, University of Texas Health Science Center at Houston
6431 Fannin St., Suite 3.262, Houston, TX 77030
Email: carlos.carreno@uth.tmc.edu